(Q53655049)

16 May 2018

title

Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen. (English)

1 reference

16 May 2018

1 reference

6

Vidadi Yusibov

1 reference

16 May 2018

author name string

Vidyashankara Iyer

1

1 reference

16 May 2018

Mangala Roshan Liyanage

2

1 reference

16 May 2018

Yoko Shoji

3

1 reference

16 May 2018

Jessica A Chichester

4

1 reference

16 May 2018

R Mark Jones

5

1 reference

16 May 2018

Sangeeta B Joshi

7

1 reference

16 May 2018

C Russell Middaugh

8

1 reference

16 May 2018

publication date

28 February 2012

1 reference

16 May 2018

Human Vaccines & Immunotherapeutics

published in

1 reference

16 May 2018

volume

8

1 reference

16 May 2018

issue

4

1 reference

16 May 2018

page(s)

453-464

1 reference

16 May 2018

The annual production cycle for influenza vaccine

cites work

1 reference

Confronting the avian influenza threat: vaccine development for a potential pandemic.

21 January 2018

1 reference

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

21 January 2018

1 reference

21 January 2018

1 reference

Pandemic influenza A (H1N1) 2009: the experience of the first six months.

21 January 2018

1 reference

FluBlok, a next generation influenza vaccine manufactured in insect cells

21 January 2018

1 reference

FluBlok, a recombinant hemagglutinin influenza vaccine

21 January 2018

1 reference

H1N1 Influenza Virus-Like Particles: Physical Degradation Pathways and Identification of Stabilizers

21 January 2018

1 reference

Development of a novel recombinant influenza vaccine in insect cells.

21 January 2018

1 reference

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs

21 January 2018

1 reference

Evidence for host-cell selection of influenza virus antigenic variants

21 January 2018

1 reference

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond

21 January 2018

1 reference

A launch vector for the production of vaccine antigens in plants

21 January 2018

1 reference

K2D2: estimation of protein secondary structure from circular dichroism spectra.

21 January 2018

1 reference

The hemagglutinin structure of an avian H1N1 influenza A virus

21 January 2018

1 reference

Composition and functions of the influenza fusion peptide

21 January 2018

1 reference

21 January 2018

Viral membrane fusion

1 reference

Preferential hydration and the exclusion of cosolvents from protein surfaces.

21 January 2018

1 reference

Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites

21 January 2018

1 reference

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid

21 January 2018

1 reference

Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity

21 January 2018

1 reference

Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity

21 January 2018

1 reference

Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.

21 January 2018

1 reference

Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza

21 January 2018

1 reference

Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study

21 January 2018

1 reference

Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

21 January 2018

1 reference

Plant-expressed HA as a seasonal influenza vaccine candidate

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4161/HV.19106

1 reference

16 May 2018

1 reference

16 May 2018